Effect of weight loss on subclinical myocardial injury: A clinical trial comparing gastric bypass surgery and intensive lifestyle intervention

Aims To investigate the effect of weight loss induced by bariatric surgery and intensive lifestyle intervention on levels of circulating high-sensitivity cardiac troponin I. Methods and Results We measured high-sensitivity cardiac troponin I concentrations pre- and 12 months post-intervention in 136 subjects with morbid obesity participating in a controlled clinical trial comparing the effect of intensive lifestyle intervention vs. Roux-en-Y gastric bypass. At baseline median (interquartile range) high-sensitivity cardiac troponin I levels were 2.40 (1.28–3.95) ng/L in the bariatric surgery group and 2.35 (1.38–4.40) ng/L in the intensive lifestyle intervention group (p = 0.736). The high-sensitivity cardiac troponin I concentration in a normal-weight control group was 0.90 (0.60–2.13) ng/L. During 12 months of follow-up, high-sensitivity cardiac troponin I decreased significantly more in the bariatric surgery group than in the intensive lifestyle intervention group (0.80 (0–1.80) vs. 0.15 (−0.50 to 1.00) ng/L; p = 0.002). In a multivariate logistic regression model, surgery emerged as a predictor of reduction in high-sensitivity cardiac troponin I levels (odds ratio 2.32; 95% confidence intervals 1.03–5.22; p = 0.041) independent of age, gender and other possible confounding baseline variables. In subsequent multivariate analyses, reductions in body weight and triglycerides emerged as possible mediators of reduction in circulating levels of high-sensitivity cardiac troponin I. Conclusion In patients with morbid obesity, bariatric surgery was associated with a significantly greater reduction in high-sensitivity cardiac troponin I, an index of subclinical myocardial injury, than intensive lifestyle intervention. The reduction appeared to be mediated by reductions in body weight and serum triglycerides. This suggests that weight loss following bariatric surgery may reduce cardiometabolic stress and subsequent risk of heart failure.

[1]  D. Bluemke,et al.  Weight loss and progressive left ventricular remodelling: The Multi-Ethnic Study of Atherosclerosis (MESA) , 2015, European journal of preventive cardiology.

[2]  S. Blankenberg,et al.  High-sensitivity cardiac troponin I in the general population – defining reference populations for the determination of the 99th percentile in the Gutenberg Health Study , 2015, Clinical chemistry and laboratory medicine.

[3]  J. D. de Lemos,et al.  Impact of sex on the prognostic value of high-sensitivity cardiac troponin I in the general population: the HUNT study. , 2015, Clinical chemistry.

[4]  G. Reboldi,et al.  Left Ventricular Hypertrophy and Obesity: Only a Matter of Fat? , 2015, High Blood Pressure & Cardiovascular Prevention.

[5]  A. Folsom,et al.  Obesity, subclinical myocardial injury, and incident heart failure. , 2014, JACC. Heart failure.

[6]  A. Keech,et al.  Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease). , 2014, Journal of the American College of Cardiology.

[7]  V. Salomaa,et al.  High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort. , 2014, European heart journal.

[8]  J. Grapsa,et al.  The effect of bariatric surgery on echocardiographic indices: a review of the literature , 2013, European journal of clinical investigation.

[9]  A. M. Leone,et al.  Effects of bariatric surgery on cardiac remodeling: clinical and pathophysiologic implications. , 2013, International journal of cardiology.

[10]  A. Siegbahn,et al.  High-sensitive cardiac troponin T and its relations to cardiovascular risk factors, morbidity, and mortality in elderly men. , 2013, American heart journal.

[11]  Avis J. Thomas,et al.  Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. , 2013, JAMA.

[12]  L. Lind,et al.  Cardiac troponin I levels measured with a high-sensitive assay increase over time and are strong predictors of mortality in an elderly population. , 2013, Journal of the American College of Cardiology.

[13]  S. Solomon,et al.  Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. , 2013, Journal of the American College of Cardiology.

[14]  L. Sjöström.  Review of the key results from the Swedish Obese Subjects (SOS) trial – a prospective controlled intervention study of bariatric surgery , 2013, Journal of internal medicine.

[15]  H. Buchwald,et al.  Metabolic/Bariatric Surgery Worldwide 2011 , 2013, Obesity Surgery.

[16]  C. Ayers,et al.  Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population. , 2013, Journal of the American College of Cardiology.

[17]  D. Siscovick,et al.  Physical activity, change in biomarkers of myocardial stress and injury, and subsequent heart failure risk in older adults. , 2012, Journal of the American College of Cardiology.

[18]  A. Høiseth,et al.  Troponin I measured by a high-sensitivity assay in patients with suspected reversible myocardial ischemia: data from the Akershus Cardiac Examination (ACE) 1 study. , 2012, Clinical chemistry.

[19]  Fred S Apple,et al.  Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. , 2012, Clinical chemistry.

[20]  C. Bouchard,et al.  Bariatric surgery and long-term cardiovascular events. , 2012, JAMA.

[21]  F. Crea,et al.  Cardiovascular risk in obesity: different activation of inflammation and immune system between obese and morbidly obese subjects. , 2011, European journal of internal medicine.

[22]  Eric Boerwinkle,et al.  Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study , 2011, Circulation.

[23]  S. Hunt,et al.  Favorable changes in cardiac geometry and function following gastric bypass surgery: 2-year follow-up in the Utah obesity study. , 2011, Journal of the American College of Cardiology.

[24]  A. Khera,et al.  Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. , 2010, JAMA.

[25]  M. Zhan,et al.  Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. , 2010, JAMA.

[26]  T. Jenssen,et al.  Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention , 2010, European journal of endocrinology.

[27]  U. Kyle,et al.  Progressive regression of left ventricular hypertrophy two years after bariatric surgery. , 2010, The American journal of medicine.

[28]  M. Pfeffer,et al.  A sensitive cardiac troponin T assay in stable coronary artery disease. , 2009, The New England journal of medicine.

[29]  T. Jenssen,et al.  Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucose. , 2009, European journal of endocrinology.

[30]  M. Robson,et al.  Beneficial cardiovascular effects of bariatric surgical and dietary weight loss in obesity. , 2009, Journal of the American College of Cardiology.

[31]  L. Orci,et al.  Forgotten but not gone: the rediscovery of fatty heart, the most common unrecognized disease in America. , 2007, Circulation research.

[32]  William Caplan,et al.  Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. , 2007, Journal of the American Dietetic Association.

[33]  Benjamin D. Levine,et al.  Cardiac Steatosis in Diabetes Mellitus: A 1H-Magnetic Resonance Spectroscopy Study , 2007, Circulation.

[34]  R. Leach,et al.  The obesity epidemic, metabolic syndrome and future prevention strategies , 2004, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[35]  P. Whelton,et al.  Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. , 2001, Archives of internal medicine.

[36]  Who Consultation on Obesity.  Obesity: preventing and managing the global epidemic. Report of a WHO consultation. , 2000, World Health Organization technical report series.

[37]  B. Howard,et al.  Relations of left ventricular mass to fat-free and adipose body mass: the strong heart study. The Strong Heart Study Investigators. , 1998, Circulation.

[38]  D. Levy,et al.  The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. , 1991, JAMA.

[39]  HELEN B. HUBERT,et al.  Obesity as an Independent Risk Factor for Cardiovascular Disease: A 26‐year Follow‐up of Participants in the Framingham Heart Study , 1983, Circulation.